Lantern Pharma to Host Second Quarter 2020 Operating and Financial Results Conference Call on July 30, 2020
- Friday, July 24, 2020, 7:14
- PR Newswire
- Add a comment
DALLAS, July 24, 2020 /PRNewswire/ — Lantern Pharma (NASDAQ: LTRN), a clinical stage biotechnology company using its proprietary RADR® artificial intelligence (“A.I.”) platform to improve drug discovery and development and, identify patients who will benefit from its portfolio of…
About the Author
admin has written 21066 stories on this site.